The AADA warns that dermatologists could face a 6% Medicare payment reduction in 2027 despite CMS revisions to modifier 25 policies.
|Videos|November 16, 2022
Pointers With Portela: Questionable Beauty Hacks
Author(s)Dustin Portela, DO
In this week’s Pointers with Dr Portela, the 208SkinDoc reacts to questionable online beauty hacks.
Advertisement
Dustin Portela, DO, a board-certified dermatologist and dermatologic surgeon at Treasure Valley Dermatology in Boise, Idaho, reacts to some of the more questionable beauty hacks being shared on TikTok.
Opinions expressed are that of Portela and do not express the views or opinions of Dermatology Times®.
Advertisement
Related to this article
Pediatric dermatologists outline how to evaluate suspected topical steroid withdrawal, exclude mimics, and preserve family trust in eczema care.
Diego Ruiz Dasilva, MD, and Lindsey Finklea, MD, discuss the burden of chronic inducible urticaria and phase 3 remIND findings for remibrutinib.
Doral Fredericks, PharmD, MBA, discusses how life stages, mental health, and reproductive concerns can shape dermatologic care for women.
Gaurav Singh, MD, MPH, explains how pharmacokinetics, trial design, and real-world tolerability set sonidegib apart from vismodegib in locally advanced basal cell carcinoma and when to start systemic therapy earlier.
Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.
Dermatology Times is looking back on the top stories in dermatology from the month of October.
From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.
Advertisement
Advertisement
Trending on Dermatology Times
1
AADA Warns of 6% Medicare Payment Cut for Dermatologists in 2027
2
Don't Be Rash: Navigating Topical Steroid Withdrawal Concerns in Pediatric Eczema
3
Systemic Therapy Selection in Pediatric and Adult Atopic Dermatitis
4
Women’s Health Needs in Psoriasis and Atopic Dermatitis
5